SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-224909
Filing Date
2012-05-10
Accepted
2012-05-10 14:06:56
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d317232d10q.htm 10-Q 562786
2 DRUG DEVELOPMENT PARTNERSHIP AND LICENSE AGREEMENT d317232dex101.htm EX-10.1 443717
3 SECTION 302 CEO CERTIFICATION d317232dex311.htm EX-31.1 9553
4 SECTION 302 CFO CERTIFICATION d317232dex312.htm EX-31.2 9683
5 SECTION 906 CEO CERTIFICATION d317232dex321.htm EX-32.1 2868
6 SECTION 906 CFO CERTIFICATION d317232dex322.htm EX-32.2 3013
  Complete submission text file 0001193125-12-224909.txt   2303847

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cris-20120331.xml EX-101.INS 198387
8 XBRL TAXONOMY EXTENSION SCHEMA cris-20120331.xsd EX-101.SCH 10904
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cris-20120331_cal.xml EX-101.CAL 29742
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20120331_lab.xml EX-101.LAB 100603
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20120331_pre.xml EX-101.PRE 65478
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30347 | Film No.: 12829464
SIC: 2836 Biological Products, (No Diagnostic Substances)